Default company panoramic image

ClearCell Therapeutics

ClearCell is a groundbreaking stemcell company with a novel cell processing technology platform addressing more than 40 genetic diseases.

  • Stage Concept Only
  • Industry Biotechnology
  • Location Vancouver, BC, Canada
  • Currency USD
  • Founded May 2012
  • Employees 2
  • Website

Company Summary

ClearCell Therapeutics is a cell therapeutics firm that is developing a cell processing technology that would bypass the need to develop individual biopharmaceuticals for cancer and more than 40 genetic diseases. The technology enables a novel platform approach to cell processing that could prevent Graft versus Host Disease (GvHD), the need for donor-recipient cell matching, and eliminate the need/expense of lifelong immunosuppressive drugs.


  • Default avatar
    Dr. Chris Russell

    Dr. Chris Russell (PhD Medical Genetics, University of British Columbia ), co-founder ClearCell Therapeutics, is a big picture scientist, international lecturer and innovator with over 15 years in R&D of stem cell culture and manipulation, business development, and consulting in the areas of genetics .Chris has a BS.C in microbiology University of British Columbia (UBC), after which he then continued with a Ph.D in Medical genetics.

  • Default avatar
    Gary Dos Santos

    Gary Dos Santos (MSc University of McGill), is a senior scientist and researcher, specialized in late-stage development of stem-cell based therapeutics. Gary has worked directly on over 20 separate drug development projects that notably include several industry firsts; a biological drug that trained the immune to recognize cancer, a drug designed to target a cancer stem cell, and an antibody drug designed to mobilize stem cells into blood.

Previous Investors

  • Default avatar
    Greenfield Business Labs